Pharmaceutical policies and regulations of oral antiviral drugs for treatment of hepatitis C in Egypt—case study

被引：0
|
作者：
Mahmoud H. Teaima
Adi Al-Nuseirat
Dalia Abouhussein
Osama A. Badary
Mohamed A. El-Nabarawi
机构：
[1] Cairo University,Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy
[2] World Health Organization Office for the Eastern Mediterranean Region,Access to Medicines and Health Technologies Unit
[3] Egyptian Drug Authority (EDA),Pharmaceutics Department
[4] The British University in Egypt,Department of Clinical Pharmacy Practice, Faculty of Pharmacy
来源：
Journal of Pharmaceutical Policy and Practice | / 14卷
关键词：
Pharmaceutical regulations; Direct-acting antivirals; Hepatitis C virus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Depression among adults with chronic hepatitis C on antiviral treatment in Port-Said, Egypt
    Abbas S.M.
    Salama H.M.
    Nour-Eldein H.
    Journal of Public Health, 2018, 26 (6) : 679 - 686
  • [22] Do oral antiviral drugs used in the treatment of chronic hepatitis B cause erectile dysfunction?
    Uzel, Ali
    Ebik, Berat
    Bucaktepe, Gamze Erten
    Yolacan, Ramazan
    Karabulut, Umit
    Ucmak, Feyzullah
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 36 (02) : 184 - 189
  • [23] Prevention and management of treatment failure to new oral hepatitis C drugs
    Benitez-Gutierrez, Laura
    Barreiro, Pablo
    Labarga, Pablo
    de Mendoza, Carmen
    Fernandez-Montero, Jose V.
    Arias, Ana
    Pena, Jose M.
    Soriano, Vicente
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (09) : 1215 - 1223
  • [24] Antiviral treatment in acute hepatitis C
    Macedo, G
    Correia, A
    Ribeiro, T
    HEPATO-GASTROENTEROLOGY, 2003, 50 (52) : 1057 - 1059
  • [25] Ocular effects of hepatitis c virus antiviral drugs
    Mohammed, Thanaa H.
    Saad, Ali H.
    Yosef, Tarek M.
    Lamee, Remon G.
    JOURNAL OF THE EGYPTIAN OPHTHALMOLOGICAL SOCIETY, 2018, 111 (01) : 1 - 6
  • [26] Interferons and other antiviral drugs in the treatment of hepatitis B and C virus infections - Preface
    Jirillo, E
    CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (11)
  • [27] SCREENING OF ANTIVIRAL DRUGS FOR TREATMENT OF HEPATITIS-B
    TSIQUAYE, KN
    COLLINS, P
    ZUCKERMAN, AJ
    JOURNAL OF HEPATOLOGY, 1986, 3 : S45 - S48
  • [28] Public reimbursement policies in Canada for direct-acting antiviral treatment of hepatitis C virus infection: A descriptive study
    Snell, Gaelen
    Marshall, Alison D.
    van Gennip, Jennifer
    Bonn, Matthew
    Butler-McPhee, Janet
    Cooper, Curtis L.
    Kronfli, Nadine
    Williams, Sarah
    Bruneau, Julie
    Feld, Jordan J.
    Janjua, Naveed Z.
    Klein, Marina
    Cunningham, Nance
    Grebely, Jason
    Bartlett, Sofia R.
    CANADIAN LIVER JOURNAL, 2023, 6 (02): : 190 - 200
  • [29] Economic analysis of Egypt's hepatitis C control policies
    Haacker, M.
    Elshalakani, A.
    Elsaeed, K.
    Hammad, R.
    Kandeel, A.
    Massiah, E.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 : 15 - 15
  • [30] Impact of treatment on hepatitis C virus transmission and incidence in Egypt: A case for treatment as prevention
    Ayoub, H. H.
    Abu-Raddad, L. J.
    JOURNAL OF VIRAL HEPATITIS, 2017, 24 (06) : 486 - 495
12345